Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 14 | 2003 | 371 | 0.580 |
Why?
|
| Obesity | 3 | 2011 | 1076 | 0.450 |
Why?
|
| Diet, Gluten-Free | 1 | 2013 | 4 | 0.440 |
Why?
|
| Glutens | 1 | 2013 | 10 | 0.440 |
Why?
|
| Celiac Disease | 1 | 2013 | 17 | 0.430 |
Why?
|
| Hypersensitivity | 1 | 2013 | 52 | 0.420 |
Why?
|
| Glycation End Products, Advanced | 3 | 2011 | 125 | 0.410 |
Why?
|
| Periodontal Diseases | 1 | 2012 | 54 | 0.400 |
Why?
|
| Rutin | 2 | 2009 | 4 | 0.350 |
Why?
|
| Vitamin E | 8 | 2001 | 55 | 0.350 |
Why?
|
| Genomics | 1 | 2011 | 168 | 0.350 |
Why?
|
| Cholesterol | 8 | 2003 | 331 | 0.320 |
Why?
|
| Dementia | 1 | 2010 | 158 | 0.310 |
Why?
|
| Cognition Disorders | 1 | 2010 | 342 | 0.280 |
Why?
|
| Physician Assistants | 2 | 2021 | 47 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1085 | 0.220 |
Why?
|
| Lipoproteins, LDL | 3 | 1995 | 343 | 0.210 |
Why?
|
| Collagen | 1 | 2005 | 636 | 0.210 |
Why?
|
| Allied Health Occupations | 1 | 2002 | 11 | 0.200 |
Why?
|
| Nutrition Assessment | 1 | 2002 | 43 | 0.200 |
Why?
|
| Computer-Assisted Instruction | 1 | 2002 | 74 | 0.190 |
Why?
|
| Compartment Syndromes | 2 | 2011 | 13 | 0.180 |
Why?
|
| Abdomen | 2 | 2011 | 80 | 0.180 |
Why?
|
| Occupational Therapy | 1 | 2021 | 80 | 0.170 |
Why?
|
| Histones | 2 | 2011 | 111 | 0.170 |
Why?
|
| Cholestanols | 4 | 1996 | 4 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2004 | 561 | 0.160 |
Why?
|
| Swine | 14 | 2003 | 672 | 0.150 |
Why?
|
| Humans | 19 | 2021 | 68618 | 0.140 |
Why?
|
| Linoleic Acids | 5 | 1996 | 12 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2011 | 867 | 0.140 |
Why?
|
| Dietary Fats | 4 | 2000 | 103 | 0.140 |
Why?
|
| Life Style | 2 | 2011 | 338 | 0.130 |
Why?
|
| Lipid Peroxides | 3 | 1995 | 19 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2011 | 84 | 0.120 |
Why?
|
| Endothelium | 3 | 1995 | 98 | 0.120 |
Why?
|
| Mass Screening | 2 | 2011 | 843 | 0.120 |
Why?
|
| Cells, Cultured | 15 | 2003 | 2673 | 0.120 |
Why?
|
| Linoleic Acid | 6 | 2003 | 13 | 0.110 |
Why?
|
| Algorithms | 2 | 2010 | 1196 | 0.110 |
Why?
|
| Oxidation-Reduction | 6 | 2005 | 567 | 0.110 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 10 | 0.110 |
Why?
|
| Wound Healing | 1 | 1995 | 260 | 0.110 |
Why?
|
| Adenosine | 2 | 2011 | 165 | 0.110 |
Why?
|
| Acremonium | 3 | 1998 | 4 | 0.100 |
Why?
|
| Plant Poisoning | 3 | 1998 | 4 | 0.100 |
Why?
|
| Antibodies | 1 | 2013 | 241 | 0.100 |
Why?
|
| Autistic Disorder | 1 | 2013 | 77 | 0.100 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2011 | 10 | 0.100 |
Why?
|
| Theophylline | 1 | 2011 | 22 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 186 | 0.100 |
Why?
|
| Cholestanes | 1 | 1991 | 2 | 0.100 |
Why?
|
| Fatty Acids | 6 | 1996 | 222 | 0.100 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 8 | 0.100 |
Why?
|
| Biopsy | 1 | 2013 | 540 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 63 | 0.090 |
Why?
|
| Physical Examination | 1 | 2011 | 152 | 0.090 |
Why?
|
| Proteoglycans | 3 | 1996 | 103 | 0.090 |
Why?
|
| Pharmacogenetics | 1 | 2011 | 47 | 0.090 |
Why?
|
| Aging | 3 | 2009 | 911 | 0.090 |
Why?
|
| Animals | 25 | 2011 | 20881 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 240 | 0.090 |
Why?
|
| Poaceae | 3 | 1998 | 12 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2011 | 381 | 0.080 |
Why?
|
| Flavonoids | 1 | 2009 | 109 | 0.080 |
Why?
|
| Pressure | 1 | 2009 | 252 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2009 | 144 | 0.080 |
Why?
|
| Models, Organizational | 1 | 2009 | 97 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2009 | 106 | 0.080 |
Why?
|
| Ammonia | 2 | 1998 | 28 | 0.080 |
Why?
|
| Seeds | 2 | 1998 | 23 | 0.080 |
Why?
|
| Influenza Vaccines | 1 | 2008 | 56 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2009 | 249 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2009 | 172 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2008 | 79 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2009 | 90 | 0.070 |
Why?
|
| Vaccination | 1 | 2008 | 189 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1140 | 0.070 |
Why?
|
| Fluorescence | 1 | 2005 | 104 | 0.060 |
Why?
|
| Lysine | 1 | 2005 | 96 | 0.060 |
Why?
|
| Arginine | 1 | 2005 | 102 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 439 | 0.060 |
Why?
|
| Albumins | 5 | 1993 | 72 | 0.060 |
Why?
|
| Health Behavior | 2 | 2010 | 458 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2005 | 175 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 565 | 0.060 |
Why?
|
| Kentucky | 1 | 2004 | 13 | 0.060 |
Why?
|
| Serum Albumin | 3 | 1995 | 104 | 0.060 |
Why?
|
| Pulmonary Artery | 3 | 1996 | 323 | 0.060 |
Why?
|
| Glucose | 1 | 2005 | 307 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2009 | 703 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2011 | 1615 | 0.060 |
Why?
|
| Permeability | 4 | 1990 | 131 | 0.050 |
Why?
|
| Liver | 3 | 2000 | 1118 | 0.050 |
Why?
|
| Physical Therapy Specialty | 1 | 2002 | 39 | 0.050 |
Why?
|
| Carnosine | 1 | 2001 | 3 | 0.050 |
Why?
|
| Histidine | 1 | 2001 | 17 | 0.050 |
Why?
|
| Hypertension | 1 | 2010 | 1535 | 0.050 |
Why?
|
| Education, Nursing | 1 | 2002 | 55 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2324 | 0.050 |
Why?
|
| Biomarkers | 3 | 2011 | 1593 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 955 | 0.050 |
Why?
|
| School Admission Criteria | 1 | 2021 | 36 | 0.050 |
Why?
|
| Cat Diseases | 1 | 2000 | 7 | 0.050 |
Why?
|
| Child | 1 | 2011 | 6405 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2021 | 67 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2002 | 230 | 0.040 |
Why?
|
| Dietary Proteins | 1 | 2000 | 51 | 0.040 |
Why?
|
| Incidence | 1 | 2004 | 1603 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2000 | 97 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2021 | 133 | 0.040 |
Why?
|
| Glutathione | 2 | 2003 | 343 | 0.040 |
Why?
|
| Cattle | 4 | 2011 | 475 | 0.040 |
Why?
|
| Spleen | 3 | 1998 | 301 | 0.040 |
Why?
|
| Students | 1 | 2021 | 233 | 0.040 |
Why?
|
| Risk Factors | 2 | 2009 | 5731 | 0.040 |
Why?
|
| United States | 3 | 2009 | 7367 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 805 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 396 | 0.040 |
Why?
|
| Weight Loss | 1 | 2000 | 319 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2001 | 1745 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 3 | 1991 | 43 | 0.030 |
Why?
|
| Male | 10 | 2011 | 37321 | 0.030 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1996 | 2 | 0.030 |
Why?
|
| DNA | 3 | 1995 | 597 | 0.030 |
Why?
|
| Eicosanoids | 1 | 1995 | 16 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 1996 | 718 | 0.030 |
Why?
|
| Body Weight | 4 | 2000 | 554 | 0.030 |
Why?
|
| Cell Division | 3 | 1990 | 541 | 0.030 |
Why?
|
| Arteriosclerosis | 2 | 1995 | 137 | 0.030 |
Why?
|
| Biological Transport | 2 | 1993 | 210 | 0.030 |
Why?
|
| Cell Membrane Permeability | 2 | 1991 | 59 | 0.030 |
Why?
|
| Plant Extracts | 1 | 1993 | 122 | 0.030 |
Why?
|
| APACHE | 1 | 2011 | 41 | 0.020 |
Why?
|
| Organ Size | 3 | 1998 | 242 | 0.020 |
Why?
|
| Ketocholesterols | 1 | 1991 | 1 | 0.020 |
Why?
|
| Dehydrocholesterols | 1 | 1991 | 3 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 1991 | 10 | 0.020 |
Why?
|
| Cytokines | 2 | 2011 | 866 | 0.020 |
Why?
|
| Mycotoxins | 1 | 1990 | 5 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 55 | 0.020 |
Why?
|
| Pelvis | 1 | 2011 | 38 | 0.020 |
Why?
|
| Lipid Peroxidation | 3 | 1996 | 94 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2011 | 97 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 57 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 334 | 0.020 |
Why?
|
| Female | 4 | 2011 | 38074 | 0.020 |
Why?
|
| Lovastatin | 1 | 1991 | 78 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 1991 | 82 | 0.020 |
Why?
|
| Immunity | 1 | 1990 | 67 | 0.020 |
Why?
|
| Lymphocyte Activation | 3 | 1998 | 397 | 0.020 |
Why?
|
| Glyoxal | 1 | 2009 | 2 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2009 | 14 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 2083 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 284 | 0.020 |
Why?
|
| Catechols | 1 | 2009 | 14 | 0.020 |
Why?
|
| Catalase | 1 | 1990 | 85 | 0.020 |
Why?
|
| Diet Therapy | 1 | 2009 | 22 | 0.020 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 89 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 36 | 0.020 |
Why?
|
| Catecholamines | 1 | 2009 | 73 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 765 | 0.020 |
Why?
|
| Peritonitis | 1 | 2009 | 46 | 0.020 |
Why?
|
| Fruit | 1 | 2009 | 86 | 0.020 |
Why?
|
| Random Allocation | 2 | 2001 | 442 | 0.020 |
Why?
|
| Vegetables | 1 | 2009 | 76 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 271 | 0.020 |
Why?
|
| Rats | 4 | 2001 | 5300 | 0.020 |
Why?
|
| Adult | 2 | 2009 | 21403 | 0.020 |
Why?
|
| Pyrrolizidine Alkaloids | 2 | 1998 | 5 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 507 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 177 | 0.020 |
Why?
|
| Cell Survival | 2 | 1989 | 901 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2011 | 332 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2011 | 419 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 216 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2009 | 170 | 0.020 |
Why?
|
| Culture Media | 2 | 2003 | 155 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2009 | 279 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2009 | 344 | 0.020 |
Why?
|
| Proteins | 1 | 1990 | 474 | 0.020 |
Why?
|
| Sepsis | 1 | 2009 | 233 | 0.020 |
Why?
|
| Antioxidants | 2 | 2001 | 304 | 0.020 |
Why?
|
| Corn Oil | 2 | 1996 | 8 | 0.020 |
Why?
|
| Time Factors | 2 | 1991 | 4655 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1753 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 772 | 0.020 |
Why?
|
| Rabbits | 2 | 1996 | 509 | 0.020 |
Why?
|
| Hemagglutination Tests | 2 | 1998 | 16 | 0.020 |
Why?
|
| Antibody Formation | 2 | 1998 | 93 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 1330 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 581 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 2093 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 14862 | 0.020 |
Why?
|
| Chickens | 2 | 1996 | 232 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 2358 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1991 | 2550 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 2007 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 60 | 0.010 |
Why?
|
| Oxidants | 1 | 2003 | 48 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 66 | 0.010 |
Why?
|
| Middle Aged | 2 | 2011 | 21147 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 163 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 2 | 1993 | 40 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2003 | 102 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2003 | 330 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 710 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2001 | 5 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2001 | 7 | 0.010 |
Why?
|
| Hydrogen Peroxide | 2 | 1993 | 168 | 0.010 |
Why?
|
| Vitamin E Deficiency | 1 | 2001 | 4 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2003 | 432 | 0.010 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2000 | 12 | 0.010 |
Why?
|
| Fatty Acids, Essential | 1 | 2000 | 16 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2000 | 49 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2000 | 43 | 0.010 |
Why?
|
| Hysterectomy | 1 | 2000 | 64 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 351 | 0.010 |
Why?
|
| Cats | 1 | 2000 | 292 | 0.010 |
Why?
|
| Triglycerides | 1 | 2000 | 184 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7029 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 753 | 0.010 |
Why?
|
| Lipids | 1 | 2000 | 298 | 0.010 |
Why?
|
| Sheep | 1 | 1998 | 128 | 0.010 |
Why?
|
| Insulin | 1 | 2000 | 619 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2000 | 631 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 1030 | 0.010 |
Why?
|
| Fats | 1 | 1996 | 8 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1996 | 17 | 0.010 |
Why?
|
| Glutathione Reductase | 1 | 1996 | 17 | 0.010 |
Why?
|
| Amidines | 1 | 1996 | 7 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 1996 | 39 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 1996 | 22 | 0.010 |
Why?
|
| Biglycan | 1 | 1996 | 2 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 1996 | 20 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1996 | 69 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 1993 | 2791 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1996 | 144 | 0.010 |
Why?
|
| Glycosides | 1 | 1993 | 14 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 73 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1993 | 30 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 2689 | 0.010 |
Why?
|
| NADP | 1 | 1993 | 39 | 0.010 |
Why?
|
| Tritium | 1 | 1992 | 101 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1992 | 38 | 0.010 |
Why?
|
| Adenine | 1 | 1992 | 46 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1993 | 525 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1996 | 1664 | 0.010 |
Why?
|
| Deoxyribose | 1 | 1991 | 3 | 0.010 |
Why?
|
| Thiobarbiturates | 1 | 1991 | 4 | 0.010 |
Why?
|
| Peroxides | 1 | 1991 | 23 | 0.010 |
Why?
|
| Mitogens | 1 | 1990 | 45 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1990 | 94 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1990 | 80 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 532 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1990 | 119 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1996 | 1293 | 0.010 |
Why?
|
| Mice | 2 | 1993 | 8474 | 0.010 |
Why?
|
| Microbodies | 1 | 1990 | 60 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1991 | 186 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1990 | 260 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1990 | 489 | 0.010 |
Why?
|
| Horses | 1 | 1989 | 20 | 0.010 |
Why?
|
| Blood | 1 | 1989 | 40 | 0.010 |
Why?
|
| Linolenic Acids | 1 | 1989 | 3 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1989 | 181 | 0.000 |
Why?
|
| Thymidine | 1 | 1988 | 32 | 0.000 |
Why?
|
| Leucine | 1 | 1988 | 41 | 0.000 |
Why?
|
| Anticholesteremic Agents | 1 | 1988 | 49 | 0.000 |
Why?
|
| Diet | 1 | 1990 | 514 | 0.000 |
Why?
|